Current nosology of treatment resistant depression: a controversy resistant to revision
- PMID: 20563286
- PMCID: PMC2887642
- DOI: 10.2174/1745017901006010020
Current nosology of treatment resistant depression: a controversy resistant to revision
Abstract
Treatment-Resistant Depression (TRD) represents a source of ongoing clinical and nosological controversy and confusion. While no univocal consensus on its definition and specific correlation with major mood disorders has been reached to date, a progressively greater number of evidences tend to suggest a revision of current clinical nosology. Since a better assessment of TRD should be considered mandatory in order to achieve the most appropriate clinical management, this narrative review aims to briefly present current most accepted definitions of the phenomenon, speculating on its putative bipolar diathesis for some of the cases originally assessed as unipolar depression.
Keywords: Bipolar Disorder; Controversy.; Treatment Resistant Depression.
Similar articles
-
Psychopathological and sociodemographic features in treatment-resistant unipolar depression versus bipolar depression: a comparative study.BMC Psychiatry. 2018 Mar 16;18(1):68. doi: 10.1186/s12888-018-1641-y. BMC Psychiatry. 2018. PMID: 29548306 Free PMC article.
-
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?World J Biol Psychiatry. 2021 Sep;22(7):483-494. doi: 10.1080/15622975.2020.1851052. Epub 2020 Dec 8. World J Biol Psychiatry. 2021. PMID: 33289425
-
Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Depression: Experience From a Clinical Setting.J Psychiatr Pract. 2020 Jan;26(1):37-45. doi: 10.1097/PRA.0000000000000447. J Psychiatr Pract. 2020. PMID: 31913968
-
Definition of treatment-resistant depression - Asia Pacific perspectives.J Affect Disord. 2019 Feb 15;245:626-636. doi: 10.1016/j.jad.2018.11.038. Epub 2018 Nov 5. J Affect Disord. 2019. PMID: 30445388
-
ECNP consensus meeting. Bipolar depression. Nice, March 2007.Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Eur Neuropsychopharmacol. 2008. PMID: 18501566 Review.
Cited by
-
Key considerations in the pharmacological management of treatment-resistant depression.Expert Opin Pharmacother. 2021 Dec;22(17):2405-2415. doi: 10.1080/14656566.2021.1951225. Epub 2021 Jul 21. Expert Opin Pharmacother. 2021. PMID: 34252320 Free PMC article.
-
The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?Front Psychiatry. 2019 May 3;10:294. doi: 10.3389/fpsyt.2019.00294. eCollection 2019. Front Psychiatry. 2019. PMID: 31130881 Free PMC article.
-
An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects.Ann Gen Psychiatry. 2011 Sep 19;10(1):23. doi: 10.1186/1744-859X-10-23. Ann Gen Psychiatry. 2011. PMID: 21929762 Free PMC article.
-
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials.BMC Psychiatry. 2023 Jul 27;23(1):545. doi: 10.1186/s12888-023-05033-y. BMC Psychiatry. 2023. PMID: 37501135 Free PMC article.
-
Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study.BMC Psychiatry. 2020 May 13;20(1):232. doi: 10.1186/s12888-020-02642-9. BMC Psychiatry. 2020. PMID: 32404073 Free PMC article.
References
-
- Little A. Treatment-resistant depression. Am Fam Physician. 2009;80(2):167–72. - PubMed
-
- WHO. The World Health Report 2001 - Mental Health: New Understanding, New Hope. World Health Organization. The World Health Report 2001 - Mental Health: New Understa. 2001.
-
- Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243–52. - PubMed
-
- Papakostas GI, Fava M, Thase ME. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches. Biol Psychiatry. 2008;63(7):699–704. - PubMed
LinkOut - more resources
Full Text Sources